Stock Forecast 10.07.2019
Company Name : GLENMARK PHARMA
Sector : PHARMA
Positives Views
- Currently received USFDA approvals for (1) Anti-Anginal Drug and (2) Chlestrol Lowering Drugs
- Scrip is now trading at the year low of Rs.447/-
- New market opening in China
Negative Views
- Pricing of drugs in US market
Current fluctuation
Current Rate: 447 Target: 550, Duration: long term